Central Bank & Trust’s Eli Lilly LLY Stock Holding History

Central Bank & Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.64M	Buy	2,198 +93	+4%	+$95K	0.37%	66
2026 Q1	$1.94M	Sell	2,105 -13	-0.6%	-$13.2K	0.3%	72
2025 Q4	$2.28M	Sell	2,118 -42	-2%	-$40.2K	0.35%	66
2025 Q3	$1.65M	Sell	2,160 -38	-2%	-$28.3K	0.26%	79
2025 Q2	$1.71M	Sell	2,198 -75	-3%	-$58.3K	0.28%	77
2025 Q1	$1.88M	Buy	2,273 +13	+0.6%	+$10.8K	0.31%	69
2024 Q4	$1.74M	Buy	2,260 +6	+0.3%	+$4.97K	0.26%	74
2024 Q3	$2M	Sell	2,254 -298	-12%	-$268K	0.28%	76
2024 Q2	$2.31M	Sell	2,552 -328	-11%	-$262K	0.32%	65
2024 Q1	$2.24M	Sell	2,880 -224	-7%	-$159K	0.32%	66
2023 Q4	$1.81M	Sell	3,104 -298	-9%	-$174K	0.28%	71
2023 Q3	$1.83M	Sell	3,402 -13	-0.4%	-$6.7K	0.32%	64
2023 Q2	$1.6M	Sell	3,415 -78	-2%	-$32.7K	0.27%	70
2023 Q1	$1.2M	Sell	3,493 -307	-8%	-$104K	0.21%	88
2022 Q4	$1.39M	Buy	3,800 +28	+0.7%	+$9.93K	0.26%	82
2022 Q3	$1.22M	Buy	3,772 +462	+14%	+$146K	0.26%	80
2022 Q2	$1.07M	Buy	3,310 +605	+22%	+$182K	0.22%	85
2022 Q1	$775K	Buy	2,705 +186	+7%	+$47.9K	0.12%	109
2021 Q4	$696K	Sell	2,519 -100	-4%	-$25.4K	0.11%	110
2021 Q3	$605K	Sell	2,619 -131	-5%	-$32.3K	0.1%	110
2021 Q2	$631K	Sell	2,750 -188	-6%	-$37.8K	0.1%	111
2021 Q1	$549K	Sell	2,938 -25	-0.8%	-$4.89K	0.09%	113
2020 Q4	$500K	Buy	2,963 +789	+36%	+$118K	0.09%	115
2020 Q3	$322K	Buy	2,174 +185	+9%	+$28.6K	0.06%	121
2020 Q2	$327K	Buy	1,989 +893	+81%	+$137K	0.06%	119
2020 Q1	$152K	Sell	1,096 -45	-4%	-$6.18K	0.04%	135
2019 Q4	$150K	Hold	1,141	–	–	0.03%	148
2019 Q3	$128K	Hold	1,141	–	–	0.03%	153
2019 Q2	$126K	Sell	1,141 -130	-10%	-$15.3K	0.03%	150
2019 Q1	$165K	Buy	1,271 +61	+5%	+$7.42K	0.04%	148
2018 Q4	$140K	Hold	1,210	–	–	0.04%	140
2018 Q3	$130K	Hold	1,210	–	–	0.03%	143
2018 Q2	$103K	Sell	1,210 -59	-5%	-$4.85K	0.03%	148
2018 Q1	$98K	Hold	1,269	–	–	0.02%	150
2017 Q4	$107K	Hold	1,269	–	–	0.03%	159
2017 Q3	$109K	Hold	1,269	–	–	0.03%	155
2017 Q2	$104K	Sell	1,269 -378	-23%	-$30.8K	0.03%	153
2017 Q1	$138K	Sell	1,647 -346	-17%	-$27.7K	0.04%	148
2016 Q4	$146K	Hold	1,993	–	–	0.04%	143
2016 Q3	$160K	Sell	1,993 -426	-18%	-$34.1K	0.04%	137
2016 Q2	$191K	Sell	2,419 -4,967	-67%	-$374K	0.05%	128
2016 Q1	$532K	Sell	7,386 -757	-9%	-$57.3K	0.15%	89
2015 Q4	$686K	Sell	8,143 -578	-7%	-$48K	0.2%	81
2015 Q3	$729K	Buy	8,721 +1,160	+15%	+$97.9K	0.24%	77
2015 Q2	$631K	Buy	7,561 +740	+11%	+$56.4K	0.2%	83
2015 Q1	$495K	Hold	6,821	–	–	0.16%	85
2014 Q4	$471K	Buy	6,821 +415	+6%	+$28K	0.16%	95
2014 Q3	$415K	Buy	6,406 +4,908	+328%	+$311K	0.16%	100
2014 Q2	$76K	Sell	1,498 -3,876	-72%	-$231K	0.03%	155
2014 Q1	$316K	Buy	5,374 +3,876	+259%	+$216K	0.12%	105
2013 Q4	$76K	Sell	1,498 -477	-24%	-$23.9K	0.03%	155
2013 Q3	$99K	Sell	1,975 -3,882	-66%	-$203K	0.04%	140
2013 Q2	$289K	Buy	+5,857	New	+$319K	0.14%	108

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Central Bank & Trust's LLY Position: Q2 2026 in Review

Central Bank & Trust increased its Eli Lilly (LLY) stake by 4.4% in Q2 2026, buying an estimated $95K and bringing the position to 2,198 shares worth $2.64M. The position accounts for 0.37% of the portfolio, ranked #66.

Central Bank & Trust first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,103 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Central Bank & Trust held 2,198 shares of Eli Lilly worth $2.64M as of Q2 2026.
Central Bank & Trust bought 93 Eli Lilly shares in Q2 2026, an estimated $95K.
Eli Lilly made up 0.37% of Central Bank & Trust's portfolio in Q2 2026, its #66 holding.
Central Bank & Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
1,103 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Central Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.